Event Date/Time: Jun 14, 2012
End Date/Time: Jun 15, 2012
A failure of cells to undergo apoptosis is a common feature of many cancers. During the last 20 years, work in many laboratories has led to the identification and understanding of many of the key players involved in apoptosis. This conference will highlight recent developments in our current understanding of the cellular role of some of these proteins as well as how our knowledge of the basic cellular apoptotic pathways is being used to develop targeted cancer chemotherapeutic agents. Particular attention will be paid to novel agents that are currently in development or early clinical trials to exploit our understanding of the Bcl-2 family, the p53 family, death receptors and inhibitor of apoptosis proteins (IAPs).
Organizer: Gerald Cohen (University of Leicester, UK)
A list of all the invited speakers (and their talk titles) is available on the conference website at www.abcam.com/cambridgecancer.
Online registration open
Call for abstracts:
Abstracts for oral and poster presentation are invited.